caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1629158217

Teresa SorianoMD

DermatologyLos Angeles, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Teresa Soriano's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 16 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Emma Taylor
Dermatology · Los Angeles, CA
82416
Scott Binder
Pathology · Rancho Dominguez, CA
61351
Aparche Yang
Dermatology · Los Angeles, CA
57268
SCUMPIA, PHILIP53221
Chandra Smart
Pathology · Los Angeles, CA
41181
Donald Roback
Diagnostic Radiology · Manhattan Beach, CA
38163
REGENTS OF THE UNIV OF CALIFORNIA35158
Unilab Corporation
Clinical Laboratory · West Hills, CA
29267
George Sarantopoulos
Pathology · Los Angeles, CA
1651
Rajan Saggar
Pulmonary Disease · Los Angeles, CA
14326
Kathy Langevin
Dermatology · Los Angeles, CA
1352
YOUNG, LORRAINE1270
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,494
Unique beneficiaries
—
Total services
8,454
Distinct HCPCS
28
Medicare payment
$459K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 1,546 Dermatology providers in CA — top quintile (cohort median 2,504).
PRESCRIBING · PART D · 2024
Total Rx claims
181
Beneficiaries
—
Total drug cost
$5K
Distinct drugs
6
Brand share
0.0%
Top prescribed drugs
Fluorouracil47 claims
Cephalexin38 claims
Ketoconazole38 claims
Triamcinolone Acetonide32 claims
Imiquimod15 claims
QUALITY · MIPS · 2024
Final MIPS score
87.5
Quality
79.4
Cost
73.7
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.53%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.